About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Astrazeneca Pharma India Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
506820
ISIN Demat
INE203A01020
Book Value
271.74
NSE Code
ASTRAZEN
Dividend Yield %
0.37
Market Cap
162421.25
P/E
198.27
EPS
32.77
Face Value
2
BSE
NSE
20-Dec-2024
BSE
NSE
NSE F & O
20-Dec-2024
BSE
NSE
NSE F & O
Last Price
6496.85
Net Change
-9
% Change
-0.14%
Prev.Close
6505.85
Open
6496.55
High
6513.75
Low
6435.05
Volume
540
Last Price
6488.20
Net Change
-12.55
% Change
-0.19%
Prev.Close
6500.75
Open
6441.00
High
6534.00
Low
6440.00
Volume
3430
Value
3502571
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
6513.75
52-Week High
8139.85
52-Week Low
4050.15
Value
22244095.65
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
6534.00
52-Week High
8139.00
52-Week Low
4650.00
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Book Closure
03-Sep-18
10-Sep-18
Dividend
1200 %
05-Jul-24
Company News
12-12-2024
Astrazeneca Pharma India ...
12-12-2024
Astrazeneca Pharma India ...
09-12-2024
Astrazeneca Pharma India ...
04-12-2024
AstraZeneca Pharma India ...
19-11-2024
AstraZeneca Pharma to lau...
19-11-2024
AstraZeneca Pharma surges...
25-09-2024
Clarification sought fro...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.